ClinConnect ClinConnect Logo
Search / Trial NCT06900790

Management of Pediatric Pancreatic Calculi At a Single Center: a Retrospective Cohort Study

Launched by YIFAN DENG · Mar 23, 2025

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

Pancreatic Duct Stones Ercp Frey Surgery

ClinConnect Summary

This clinical trial is looking at how to best manage children with pancreatic duct stones, which are hard deposits that can form in the pancreas. The researchers want to compare two main treatments: a procedure called ERCP, which uses a camera to help remove the stones, and surgery, to see which is more effective and when surgery should be done if kids have had multiple ERCPs. The goal is to find ways to treat these stones while minimizing any harm to the surrounding areas.

To participate in this study, children must be between 0 to 18 years old and have been diagnosed with pancreatic duct stones through imaging tests like ultrasound or CT scans. They should have received care at the pediatric surgery department at West China Hospital from 2014 to 2025. If a child has had certain previous surgeries or has serious health issues, they may not be eligible. Overall, the study aims to gather important information that could improve treatment options for kids with this condition in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients aged 0 to 18 years
  • Diagnosed with pancreatic duct stones by imaging (e.g., ultrasound, CT, MRCP)
  • Treated and followed at pediatric surgery, west china hospital, between 2014 and 2025
  • Complete clinical data available for review
  • Exclusion Criteria:
  • Pancreatic duct stones secondary to previous pancreatic or biliary surgery
  • Concurrent severe systemic diseases (e.g., advanced cardiac, renal, or hepatic disease)
  • Incomplete or missing key clinical records

About Yifan Deng

Yifan Deng is an innovative clinical trial sponsor dedicated to advancing healthcare through rigorous research and development. With a strong focus on improving patient outcomes, Yifan Deng emphasizes the importance of ethical standards and scientific integrity in all clinical studies. The organization collaborates with leading researchers and healthcare professionals to design and implement trials that explore novel therapies and treatment modalities. Committed to transparency and collaboration, Yifan Deng strives to contribute valuable insights to the medical community, ultimately enhancing the quality of care for patients worldwide.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported